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http:WHAT THIS PAPER ADDS
Computed tomography angiography is the gold standard for fenestrated endovascular aneurysm repair (FEVAR)
follow up. Radiation, the nephrotoxic contrast, and costs limit its use. The data herein suggest an alternative
protocol for FEVAR follow up in selected patients.Objective: To evaluate four-dimensional contrast-enhanced ultrasound (4D-CEUS) as an alternative imaging
method to computed tomography angiography (CTA) during follow up of fenestrated endovascular aneurysm
repair (FEVAR) for juxta- and para-renal abdominal aortic aneurysms (AAA).
Methods: Between October 2011 and March 2012, all consecutive patients who underwent FEVAR follow up
were included in the study and evaluated with both 4D-CEUS and CTA. The interval between the two
examinations was always 30 days. Endpoints were the comparison of postoperative AAA diameter, AAA
volume, presence of endoleaks, revascularized visceral vessel (RVV) visualization, and patency. Comparative
analysis was performed using BlandeAltman plots and McNemar’s Chi-square test.
Results: Twenty-two patients (96% male, 4% female; mean age 74  7 years; American Society of
Anesthesiologists grade III/IV 82%/18%) were enrolled. Seventy-eight RVV (fenestrations: 60; scallops: 17;
branches: 1) were analyzed. The mean AAA diameter evaluated by 4D-CEUS and CTA was 45  10 mm (range
30e69 mm) and 48  9 mm (range 32e70 mm), respectively. The mean difference was 3  3 mm. The mean AAA
volume evaluated by 4D-CEUS and CTA was 150  7 cc (range 88e300 cc) and 159  68 cc (range 80e310 cc),
respectively. The mean difference was 7  4 cc; a BlandeAltman plot revealed agreement in AAA diameter and
volume evaluation (p < .01) between 4D-CEUS and CTA. The observed agreement for the detection of endoleaks
was 95%. McNemar’s Chi-square test conﬁrmed that 4D-CEUS and CTA were equivalent (p > .05) at detecting
endoleaks. The ﬁrst segment of six (8%) RVVs (four renal and two superior mesenteric arteries) was not directly
visualized by 4D-CEUS owing to obesity, but the contrast enhancement into the distal part of vessel or into the
relative parenchyma gave indirect information about their patency. McNemar’s Chi-square test demonstrated the
superiority of CTA (p ¼ .031) in visualizing RVVs. The patency of 77/78 RVVs was conﬁrmed with both techniques.
McNemar’s Chi-square test conﬁrmed that 4D-CEUS and CTA were equivalent in their ability to detect visceral
vessel patency.
Conclusions: The data suggest that 4D-CEUS is as accurate as CTA in the evaluation of postoperative AAA
diameter and volume, endoleak detection, and RVV patency after FEVAR. Four-dimensional CEUS could provide
hemodynamic information regarding RVVs, and reduce radiation exposure and renal impairment during follow
up. Obesity limits the diagnostic accuracy of 4D-CEUS.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Single- and multicentre experience has suggested that
fenestrated endovascular aneurysm repair (FEVAR) is a well
established therapeutic option to treat juxta- and para-renal
abdominal aortic aneurysms (AAAs) with low mortality/
morbidity and satisfactory intermediate outcomes.1e3
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higher incidence of secondary interventions due to com-
plications, that in the case of FEVAR include endoleaks,
migration, and target vessel or iliac leg occlusions.4e6 Strict
follow up is therefore mandatory to detect and correct
these complications. Nowadays, computed tomography
angiography (CTA) is considered the gold standard for
FEVAR follow up,1e3,6 but the cumulative radiation dose,
nephrotoxic contrast agent use, and high cost limit its use as
a lifelong surveillance tool.
Contrast-enhanced ultrasound (CEUS) has a high sensi-
bility and speciﬁcity in detecting and classifying endoleaks
in standard EVAR follow up,7e10 and a recent study suggests
its use for FEVAR evaluation.11 Real-time four-dimensional
(4D) ultrasound (US) is available on new probes with matrix-
array, “fully sampled” technology, and its use has been re-
ported in cardiology, obstetrics, and interventional radi-
ology.11e14 Real-time 4D CEUS (4D-CEUS) imaging is a new
medical imaging technique that combines CEUS and 4D US
to overcome the shortcomings of incomplete scanning of
two-dimensional US images.
There are no data with regard to its application after
FEVAR. The aim of this study was to evaluate 4D-CEUS as an
alternative imaging method to CTA during the follow up of
fenestrated endografts for AAA.
METHODS
From October 2011 to March 2012, all consecutive patients
who underwent FEVAR follow up for juxta- and para-AAA
(neck length <0.5 mm) were prospectively enrolled.
FEVAR procedures were performed in a dedicated oper-
ating theatre with a C-arm OEC 9800 plus (GE Healthcare,
Salt Lake City, UT, USA) and the fenestrations were joined to
the native visceral vessels with a balloon-expandable
covered stent-graft (Advanta V12, Atrium Medical, Hud-
son, NH, USA). Indications for FEVAR included asymptom-
atic high surgical risk patients with juxta-/para-renal AAA
with a diameter between 55 and 70 mm, juxta-/para-renal
AAA with a diameter between 50 and 54 mm associated
with aortic blister, AAA growth rate of >0.5 cm/year, or
penetrating aortic ulcer with a diameter of >35 mm. The
exclusion criteria were proximal aortic neck angle >60;
iliac or common femoral artery stenotic or occlusive lesions;
severe tortuous iliac arteries; visceral vessels with a diam-
eter of <4 mm; or severe stenosis (>70%).
Patients were evaluated with both CEUS/4DCEUS and
CTA. The interval between the two examinations was always
30 days. Patients signed a speciﬁc consent form for this
follow up protocol.
The study endpoints were the comparison of post-
operative AAA diameter, AAA volume, the presence of
endoleaks, visualization and patency of revascularized
visceral vessels (RVVs).
CTA
CTA was performed by a radiologist with experience in
vascular CTA evaluations (MD). Triple-phase CTA(unenhanced, arterial contrast-enhanced, and delayed
phases [180 seconds]) was acquired on a 64-slice CT scanner
(GE Healthcare) from the thorax to the femoral artery bi-
furcations. Iodinate contrast (100e130 mL Iomeron 400;
Bracco, Milan, Italy) was injected at 4 mL/second for the
ﬁrst 100 mL and 2 mL/second for the last 30 mL. Contrast
injection was followed by saline solution (0.9% NaCl) at a
rate of 2 mL/second. Reconstructions at a slice thickness of
1 mm were performed. Patients with creatinine >1.3 mg/dL
received intravenous hydration the day before and after
CTA. Patients with a history of allergy to the iodinated
contrast were pre-medicated with corticosteroids and an-
tihistamines before the examination. The CTA was pro-
cessed on independent dedicated software for visceral
vessel analysis (3Mensio; Vascular Imaging, Bilthoeven, the
Netherlands), and evaluated by radiologists and vascular
surgeons expert in endovascular aneurysm repair (EVAR)
and FEVAR planning and procedures. The postoperative AAA
diameters and volumes were measured using center lumen
line reconstructions. Endoleaks were detected and classiﬁed
according to the White and May classiﬁcation.15 Visualiza-
tion and patency of the RVV was determined on the axial
CTA cuts and appropriate post-processing reconstructions.CEUS/4D-CEUS
All US examinations, including baseline US, CEUS, and 4D-
CEUS, were performed with the same machine (iU22 sys-
tem, software Q-Lab; Philips Medical Systems, Bothell, WA,
USA). A fully sampled matrix array with a frequency of 6.0e
1.0 MHz (x6-1; Philips Medical Systems) was used.
A sulfur hexaﬂuoride-ﬁlled microbubble contrast agent
(SonoVue; BR1, Bracco) was used for contrast examinations.
To avoid interobserver variability, all US scanning was
performed by one investigator (CS) who had more than 10
years of experience in contrast ultrasound and who was
blinded to the CTA.
The US examination started with B-mode evaluation of
the aorta by live x-plane imaging where the maximal
aneurysm diameter and the stent-graft were evaluated. The
abdominal aorta was scanned from the diaphragm to the
iliac arteries and the entire sac was analyzed to detect
possible color ﬂow within the aneurysm sac. Then, the
blood ﬂow in the visceral and renal arteries was analyzed in
color ﬂow and pulse-wave modes. Fifty percent or greater
stenosis of a stented vessel was considered signiﬁcant and
was identiﬁed using the pick systolic velocity and vessels/
aortic systolic ratio deﬁned by Aburama et al.,16 as veloc-
ities in stented vessels tend to be higher than in native
vessels.
In the CEUS mode, the unenhanced and enhanced images
were displayed simultaneously on the same screen (side-by-
side technique) to identify the aorta and the collaterals
previously evaluated with B-mode and Doppler US. Sono-
Vue (Bracco) was injected into the antecubital vein as a 2.5-
mL bolus (within 1e2 seconds), followed by a ﬂush of 10 mL
normal saline. The timer was activated promptly from the
beginning of injection. The aorta was observed for at least 2
Figure 1. BlandeAltman plot of maximum aneurysm diameter
obtained with four-dimensional contrast-enhanced ultrasound
(CEUS) and computed tomography angiography (CTA; equation of
the trendline y ¼ 0.09727  6.9689; correlation coefﬁcient
0.9424; p < .01; intercept coefﬁcient ¼ 6.9689;
slope ¼ 0.09727).
Figure 2. BlandeAltman plot of aneurysm volume obtained with
four-dimensional contrast-enhanced ultrasound (CEUS) and
computed tomography angiography (CTA; equation of the trend-
line y ¼ 0.01482  0.6149; correlation coefﬁcient 0.9955; p < .01;
intercept coefﬁcient ¼ 0.6149; slope ¼ 0.01482).
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further analysis, on the hard disk incorporated in the
machine.
When the signals from the microbubbles in the aorta
disappeared, usually 10 minutes after CEUS, a second bolus
of SonoVue (Bracco) was injected and the 4D-CEUS scanning
was performed. The X-matrix transducer was kept in a sta-
ble position without movement, and the patient was asked
to hold his/her breath for 5e10 seconds, depending on the
size of the volume data and the acquisition mode.
After 4D scanning and volume data acquisition, the vol-
ume data were retrieved and three-dimensional recon-
struction was performed using Q-Lab software (Philips
Medical Systems).
Statistical analysis
AAA diameters were expressed as mean  SD. The com-
parison of two follow up imaging methods was performed
using BlandeAltman plots. Endoleak detection, RVV visu-
alization, and patency were evaluated by McNemar’s Chi-
square test. Statistical evaluations were performed using
SPSS (v. 15.0; IBM, Armonk, NY, USA) and MedCalc software
for Windows (v. 12.2; MedCalc, Ostend, Belgium).
RESULTS
From October 2011 to March 2012, 22 patients who un-
derwent FEVAR follow up were enrolled in the study. The
mean age was 74  7 years (range 54e80 years); 96% of
patients were male; and all were American Society of An-
esthesiologists (ASA)  III (ASAIII/IV 82%/18%). Five (23%)
patients had a body mass index (BMI)  30. The mean
preoperative AAA diameter was 55  7 mm (range 48e
71 mm). Seven patients had a preoperative AAA diameter
<55 mm. Among these, one patient had a para-celiac
penetrating atherosclerotic ulcer with a maximum diam-
eter of 48 mm; four patients had an AAA growth rate of
>0.5 cm/year, one patient had an AAA with a diameter of
51 mm and a common iliac aneurysm of >3 cm diameter;
and one patient had an AAA of 50 mm diameter with an
aortic blister.
Three-modular and tube-endografts were deployed,
respectively, in 17 (77%) and ﬁve (23%) cases. A total of 78
RVVs (fenestrations: 60; scallops: 17; branches: 1) were
analyzed. Among the 22 paired imaging exams, ﬁve (23%)
were performed before the discharge (mean time 4 days
after procedure, range 2e7 days) and 17 (77%) during the
long-term follow up (mean time 19 months after procedure,
range 1e35 months).
AAA diameter and AAA volume
The mean AAA diameter evaluated by 4D-CEUS and CTA
was 45  10 mm (range 30e69 mm) and 48  9 mm (range
32e70 mm), respectively. The mean difference was
3  3 mm, with the CTA measurements tending to be
slightly larger. The mean AAA volume evaluated by 4D-CEUS
and CTA was 156  67 cc (range 75e300 cc) and
159  68 cc (range 80e310 cc), respectively. The meandifference was 3  7 cc, with the CTA measurements
tending to be slightly larger. A BlandeAltman plot revealed
agreement (p < .01) in AAA diameter and volume evalua-
tion between 4D-CEUS and CTA (only 5% of the 22 data
points were outside the limit of agreement; Figs. 1 and 2).
The linear correlations between 4D-CEUS and CTA are re-
ported in Figs. 3 and 4.Endoleak detection
Endoleaks were detected by CTA in three (14%) patients
and by CEUS/4D-CEUS in two (5%) patients (Table 1). There
were no type I or III endoleaks. Two type II endoleaks were
detected by both imaging modalities, while one type II
endoleak was visualized with CTA, but was not found by
CEUS/4D-CEUS (CEUS failed in an obese patient). The
observed agreement for endoleak detection was 96% (21/
Figure 3. Scatter diagram of diameter measurements with four-
dimensional contrast-enhanced ultrasound (CEUS) and computed
tomography angiography (CTA). Linear correlation is observed
(correlation coefﬁcient ¼ 0.9424; p < .01).
Table 1. Differences between computed tomography angiography
(CTA) and four-dimensional contrast-enhanced ultrasound (4D-
CEUS).
4D-CEUS CTA D p
AAA diameter (mm) 45  2 48  9 3  3 <.01
AAA volume (cc) 156  67 159  68 3  7 <.01
Endoleaks (%) 9 (2/22) 14 (3/22) 5 (1/22) 1.00
RVV visualization (%) 92 (72/78) 100 (78/78) 8 (6/78) .03
RVV patency (%) 100 (77/78) 100 (77/78) e 1.00
Note. Values are given as means  SD, unless otherwise indicated.
Signiﬁcant values are in bold. AAA ¼ abdominal aortic aneurysm;
RVV ¼ revascularized visceral vessel.
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and CTA were equivalent (p > .05).Target vessels
Seventy-eight RVVs were evaluated: including 43 renal ar-
teries, 21 superior mesenteric arteries (SMAs), and 14 celiac
trunks. CTA visualized all 78 RVVs, while in 6/78 (8%) the
origin of the vessels was not directly visualized by CEUS/4D-
CEUS (four renal and two SMAs),owing to obesity, in two
patients. In these cases, the contrast enhancement and
duplex ﬂow evaluation into the distal part of the vessel or
into the parenchyma showed indirect information about
their patency. McNemar’s Chi-square test demonstrated
that CTA has a higher accuracy (p ¼ .03) in visualization of
the visceral vessel origin than 4D CEUS.
The patency of 77/78 RVVs (one renal artery occlusion)
was conﬁrmed with both techniques. A ﬂow analysis using
the pulse-wave mode underlined a high systolic peak ve-
locity (>200 cm/second) in a stented SMA but CTA did not
visualize any morphologically signiﬁcant stenosis. McNe-
mar’s Chi-square test conﬁrmed that 4D-CEUS and CTAFigure 4. Scatter diagram of diameter measurements with four-
dimensional contrast-enhanced ultrasound (CEUS) and computed
tomography angiography (TC). Linear correlation is observed
(correlation coefﬁcient ¼ 0.9955; p < .01).were equivalent in their ability to detect the patency of
visceral vessels.
DISCUSSION
Previous experience suggests that the fenestrated endograft
is a well established technology for the treatment of juxta-
and para-renal AAAs, with low early mortality/morbidity
and satisfactory intermediate outcomes when compared
with open repair.1e3,17 However, fenestrated endovascular
treatments are associated with a high incidence of sec-
ondary interventions due to speciﬁc complications.5,6 The
most commonly reported late FEVAR complications are
migration, in-stent visceral stenosis/occlusion, visceral stent
fracture, endoleaks (type I, III, and persistent type II), and
limb graft stenosis/thrombosis.6,18 Some authors suggest
that they occur in 74e85% of cases in the ﬁrst year.19 For
this reason, a strict follow up is mandatory for early diag-
nosis and treatment.
CTA has a high sensitivity in detecting endoleaks and is
nowadays considered the gold standard for EVAR and
FEVAR follow up. The European Collaborators on stent-graft
Techniques for Aortic Aneurysm Repair (EUROSTAR) Regis-
try recommends CTA follow up at 1, 6, and 12 months after
the procedure and yearly thereafter.20 In evaluating the
follow up protocols of the largest FEVAR experience in the
literature,1e3,21 CTA is usually performed three times in the
ﬁrst year after the procedure. The widespread use of CTA
has important limitations: the cumulative radiation dose,
the nephrotoxic contrast agent load, and the high cost.
These limitations are exacerbated by the lifelong surveil-
lance needed for these patients. An ideal follow up protocol
should have a high sensitivity and speciﬁcity for complica-
tions without adjunctive risk or cost for the patient.
Color duplex US is non-invasive and does not use radia-
tion; it is less expensive, easy to perform, and widely
available. It has been investigated for many years as an
alternative to CTA for standard EVAR follow up. Some au-
thors suggest it is suitable, in selected cases, as the sole
imaging modality.21e23
Published experience indicates that contrast enhanced
US examination seems to improve the diagnostic sensitivity
of US imaging and its accuracy in endoleak detection. Our
previous experience with regard to follow up after standard
EVAR showed CEUS to have a high sensitivity and speciﬁcity
in the detection and classiﬁcation of endoleaks.24 These
540 M. Gargiulo et al.results were conﬁrmed by more recent and larger studies.
Perini et al.9 demonstrated that CEUS is as accurate as CTA
in endoleak detection and AAA diameter evaluation during
EVAR follow up. Similar data were reported by Mirza
et al.,25 who concluded that CEUS is a valid and comparable
alternative to CTA. Some authors claim CEUS has greater
sensitivity than CTA. Napoli et al.26 stated that the hemo-
dynamic information obtained by CEUS could detect
endoleaks missed by CTA, but conﬁrmed on conventional
digital subtraction angiography.
The only dedicated paper is by Perini et al.,11 who report
the comparison of CTA and CEUS in 62 patients who un-
derwent FEVAR. The authors concluded that CEUS is as
accurate as CTA in endoleak detection, AAA diameter
measurement, and the evaluation of visceral target vessels
during fenestrated endograft surveillance. To the best of the
author’s knowledge, this study reports the ﬁrst experience
of the application of 4D-CEUS in FEVAR follow up.
In this study, both CEUS and CTA had the same level of
accuracy in endoleak detection, with excellent agreement.
Three (14%) type II endoleaks were detected by CTA and
two (9%) were detected by CEUS. The difference between
the two imaging methods was 5%, and there were no sta-
tistically signiﬁcant differences. It is important to underline
that the only type II endoleak not detected by CEUS
occurred in an obese patient. The adjunctive hemodynamic
information obtained by CEUS, with regard to blood ﬂow
direction inside the AAA sac, allows speciﬁc evaluation of
the endoleaks. It is an important aspect in planning the best
treatment.
Both techniques were equivalent in measuring AAA
diameter and volume, and were in complete agreement
with regard to the assessment of third ventricle volume
(TVV) patency. The mean difference in AAA diameter and
volume evaluation using CTA versus CEUS was 3  3 mm.
According to the statistical analysis, there was no difference
in the information obtained by CTA and CEUS, but differ-
ences of >5 mm could be a clinical problem during EVAR or
FEVAR follow up. In the present study, in only four cases
was there a discrepancy in AAA diameter of >5 mm, and
two of these were obese patients. In these cases, annual
CTA is always indicated during follow up.
The possibility of having a multi-planar ultrasound
reconstruction, and 3D and 4D processing in real time, with
a X6-1 probe, may provide adjunctive opportunities to
better evaluate and study the AAA sac during long-term
follow up. The 3D/4D volume evaluation can be consid-
ered more accurate if compared with the single diameter
evaluation. The mean AAA volume differences between CTA
and CEUS was 3  7 cc, and there was just one case with a
volume difference of >5% measured by CTA. Certainly,
duplex US and CEUS evaluations remain the ﬁrst step during
FEVAR follow up, and, in cases of doubt, CTA is mandatory.
It is important to underline how the visualization of the
visceral vessel was not always possible by CEUS. Owing to
obesity in two patients, six vessels could not be directly
visualized. In these cases, the medium contrast enhance-
ment of relative visceral parenchyma (kidney, liver, spleen)or the exploration of the segment of SMA that runs parallel
to the aorta provide indirect information with regard to the
vessel patency, and speculative information with regard to
its patency and the absence of stenosis.
Another important aspect of postoperative FEVAR sur-
veillance is the detection of endograft migration and/or
sealing zone degeneration. With CTA, this is usually obvious
and may lead to “prophylactic” treatment. Certainly, with
DUS and CEUS it is not always possible. In the present study,
only juxta-/para-renal AAA were evaluated and in most of
these cases the proximal endograft sealing zone was in the
abdominal aorta and duplex US was usually able to visualize
the proximal endograft seal. Clearly, this information is
approximate and not as accurate as the information pro-
vided by CTA and cannot be used to plan any kind of
treatment. Indirect information regarding seal failures could
be suggested by the presence of a high-ﬂow endoleak or
reduction/absence of perfusion in the most cranial visceral
vessel. In the authors’ opinion, CEUS for these patients
could be used for screening and routine imaging during
follow up.
CEUS has some limitations that may prevent its use as the
sole imaging modality for FEVAR follow up. One of the most
important negative aspects is its “operator-dependent”
nature. The second is that some patient characteristics (e.g.,
obesity, meteorism, ascitis) can negatively inﬂuence the
examination. In the present experience, all the CEUS failures
(difﬁculty in visualization of TVV and missed type II endo-
leaks) occurred in obese patients. Another potential draw-
back of CEUS is its inability to detect stent fractures, kinking,
or component separation. Some of these can be overcome
by indirect CEUS information (acceleration or endoleak) or
adjunctive examinations as plain X-ray/stent fracture or
migration. Perini et al.11 considered the inability to evaluate
the proximal sealing zone of fenestrated endografts with
three or more fenestrations as a limitation. In the experi-
ence reported herein, the evaluation of 21 SMAs and 14
celiac trunks was reported, and in only two cases was direct
visualization of vessels not possible. The evaluation of the
proximal visceral vessel patency and the absence of endo-
leak may suggest, in the authors’ opinion, correct proximal
sealing.
An important limit of the study is the small number of
patients enrolled and, of course, the absence of statistical
differences between 4D-CEUS and CTAdresults that could
be associated with a type-1 error. It must be considered
that this is only a preliminary experience with an emerging
imaging method; to the best of the authors’ knowledge, this
is the ﬁrst reported paper with regard to the application of
CEUS/4D-CEUS with the X6-1 matrix probe in the follow up
of fenestrated endografts.
According to the preliminary data reported here and the
results of the study by Perini et al.,11 an alternative protocol
for the follow up of selected patients who underwent
FEVAR is suggested. For example, patients with a BMI <30,
without any diagnostic doubts, can undergo FEVAR follow
up with CEUS/4D-CEUS and a plain abdominal X-ray every
six months.
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The data presented here suggest that CEUS/4D-CEUS is as
accurate as CTA for the evaluation of AAA diameter/vol-
ume, endoleak detection, and RVV patency after FEVAR.
CEUS/4D-CEUS could provide hemodynamic information
with regard to RVVs. Owing to its advantages, such as non-
invasiveness, no radiation, real-time scanning, low cost,
easy performance, and continuously improving image
quality, it has gained increasing attention because it may
allow better visualization of the 3D conﬁguration of the
FEVAR, and better understanding of the spatial relationship
between FEVAR and the vessels. The reduction in radiation
exposure and renal impairment are the main advantages
during follow up. Some limitations could reduce the wide-
spread use of this imaging technique as the sole diagnostic
tool. Obesity limits the diagnostic accuracy of 4D-CEUS.
Further and larger experiences are necessary to better
deﬁne the role of 4D-CEUS in FEVAR follow up.
FUNDING
None.
CONFLICT OF INTEREST
None.REFERENCES
1 Verhoeven EL, Vourliotakis G, Bos WT, Tielliu IF, Zeebregts CJ,
Prins TR, et al. Fenestrated stent grafting for short-necked and
juxtarenal abdominal aortic aneurysm: an 8-year single-centre
experience. Eur J Vasc Endovasc Surg 2010;39(5):529e36.
2 Amiot S, Haulon S, Becquemin JP, Magnan PE, Lermusiaux P,
Gouefﬁc Y, et al. Fenestrated endovascular grafting: the French
multicentre experience. Eur J Vasc Endovasc Surg 2010;39(5):
537e44.
3 Kristmundsson T, Sonesson B, Dias N, Törnqvist P, Malina M,
Resch T. Late outcomes after fenestrated endovascular repair
for juxtarenal aortic aneurysm. J Vasc Surg 2014;59(1):115e20.
4 EVAR Trial Participants. Endovascular aneurysm repair versus
open repair in patients with abdominal aortic aneurysm (EVAR
trial 1): randomised controlled trial. Lancet 2005;365(9478):
2179e86.
5 United Kingdom EVAR Trial Investigators, Greenhalgh RM,
Brown LC, Powell JT, Thompson SG, Epstein D, Sculpher MJ.
Endovascular versus open repair of abdominal aortic aneu-
rysm. N Engl J Med 2010;362(20):1863e71.
6 Troisi N, Donas KP, Austermann M, Tessarek J, Umscheid T,
Torsello G. Secondary procedures after aortic aneurysm repair
with fenestrated and branched endografts. J Endovasc Ther
2011;18(2):146e53.
7 Cantisani V, Ricci P, Grazhdani H, Napoli A, Fanelli F, Catalano C,
et al. Prospective comparative analysis of colour-Doppler ul-
trasound, contrast-enhanced ultrasound, computed tomogra-
phy and magnetic resonance in detecting endoleak after
endovascular abdominal aortic aneurysm repair. Eur J Vasc
Endovasc Surg 2011;41(2):186e92.
8 Gürtler VM, Sommer WH, Meimarakis G, Kopp R,
Weidenhagen R, Reiser MF, et al. A comparison between
contrast-enhanced ultrasound imaging and multislice
computed tomography in detecting and classifying endoleaksin the follow up after endovascular aneurysm repair. J Vasc
Surg 2013;58(2):340e5.
9 Perini P, Sediri I, Midulla M, Delsart P, Mouton S, Gautier C,
et al. Single-centre prospective comparison between contrast-
enhanced ultrasound and computed tomography angiography
after EVAR. Eur J Vasc Endovasc Surg 2011;42(6):797e802.
10 Iezzi R, Basilico R, Giancristofaro D, Pascali D, Cotroneo AR,
Storto ML. Contrast-enhanced ultrasound versus color duplex
ultrasound imaging in the follow up of patients after endo-
vascular abdominal aortic aneurysm repair. J Vasc Surg
2009;49(3):552e60.
11 Perini P, Sediri I, Midulla M, Delsart P, Gautier C, Haulon S.
Contrast-enhanced ultrasound vs. CT angiography in fenes-
trated EVAR surveillance: a single-center comparison.
J Endovasc Ther 2012;19(5):648e55.
12 Acar P, Laskari C, Rhodes J, Pandian N, Warner K, Marx G.
Three-dimensional echocardiographic analysis of valve anat-
omy as a determinant of mitral regurgitation after surgery for
atrioventricular septal defects. Am J Cardiol 1999;83(5):745e9.
13 Jenkins C, Bricknell K, Hanekom L, Marwick TH. Reproducibility
and accuracy of echocardiographic measurements of left ven-
tricular parameters using real-time three-dimensional echo-
cardiography. J Am Coll Cardiol 2004;44(4):878e86.
14 Xiong Y, Wah YM, Chen M, Leung TY, Lau TK. Real-time three-
dimensional echocardiography using a matrix probe with live
xPlane imaging of the interventricular septum. Ultrasound
Obstet Gynecol 2009;34(5):534e7.
15 White GH, Yu W, May J, Chaufour X, Stephen MS. Endoleak as a
complication of endoluminal grafting of abdominal aortic an-
eurysms: classiﬁcation, incidence, diagnosis, and management.
J Endovasc Surg 1997;4(2):152e68.
16 AbuRahma AF, Srivastava M, Mousa AY, Dearing DD, Hass SM,
Campbell JR, et al. Critical analysis of renal duplex ultrasound
parameters in detecting signiﬁcant renal artery stenosis. J Vasc
Surg 2012;56(4):1052e9.
17 Nordon IM, Hinchliffe RJ, Holt PJ, Loftus IM, Thompson MM.
Modern treatment of juxtarenal abdominal aortic aneurysms
with fenestrated endografting and open repairda systematic
review. Eur J Vasc Endovasc Surg 2009;38(1):35e41.
18 Resch T, Sonesson B, Malina M. Incidence and management of
complications after branched and fenestrated endografting.
J Cardiovasc Surg (Torino) 2010;51(1):105e13.
19 Brown LC, Greenhalgh RM, Powell JT, Thompson SG. EVAR Trial
Participants. Use of baseline factors to predict complications
and reinterventions after endovascular repair of abdominal
aortic aneurysm. Br J Surg 2010;97(8):1207e17.
20 Leurs LJ, Laheij RJ, Buth J. EUROSTAR Collaborators. What de-
termines and are the consequences of surveillance intensity
after endovascular abdominal aortic aneurysm repair? Ann
Vasc Surg 2005;19(6):868e75.
21 Greenberg RK, Sternbergh 3rd WC, Makaroun M, Ohki T,
Chuter T, Bharadwaj P, et al. Fenestrated Investigators. Inter-
mediate results of a United States multicenter trial of fenes-
trated endograft repair for juxtarenal abdominal aortic
aneurysms. J Vasc Surg 2009;50(4):730e7.
22 Harrison GJ, Oshin OA, Vallabhaneni SR, Brennan JA, Fisher RK,
McWilliams RG. Surveillance after EVAR based on duplex ul-
trasound and abdominal radiography. Eur J Vasc Endovasc Surg
2011;42(2):187e92.
23 Verhoeven EL, Oikonomou K, Ventin FC, Lerut P,
Fernandes E, Fernandes R, et al. Is it time to eliminate CT
after EVAR as routine follow up? J Cardiovasc Surg (Torino)
2011;52(2):193e8.
542 M. Gargiulo et al.24 Mauro R, Maioli F, Freyrie A, Testi G, Palumbo N, Serra C, et al.
Is CEUS a valid alternative to CTA in endoleaks detection?
J Vasc Endovasc Surg 2010;17:253e8.
25 Mirza TA, Karthikesalingam A, Jackson D, Walsh SR, Holt PJ,
Hayes PD, et al. Duplex ultrasound and contrast-enhanced ul-
trasound versus computed tomography for the detection ofendoleak after EVAR: systematic review and bivariate meta-
analysis. Eur J Vasc Endovasc Surg 2010;39(4):418e28.
26 Napoli V, Bargellini I, Sardella SG, Petruzzi P, Cioni R, Vignali C,
et al. Abdominal aortic aneurysm: contrast-enhanced US for
missed endoleaks after endoluminal repair. Radiology
2004;233(1):217e25.
